Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glomerular Nephritis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01410747
What this trial is testing

Evaluate the Safety and Efficacy of Tacrolimus for Lupus Nephritis Under Actual Use Situations

Who this might be right for
Lupus Nephritis
Astellas Pharma Inc 1,484
Not applicableStudy completedNCT06757725
What this trial is testing

Renal Resistive Index as an Indicator of Lupus Nephritis Severity and Systemic Lupus Activity

Who this might be right for
Systemic Lupus ErthematosusLupus GlomerulonephritisLupus Flare
Kasr El Aini Hospital 75
Early research (Phase 1)Study completedNCT01845740
What this trial is testing

Phase Ib Study of SC Milatuzumab in SLE

Who this might be right for
Lupus Erythematosus, CutaneousLupus Erythematosus, DiscoidLupus Erythematosus, Systemic+2 more
Gilead Sciences 22
Early research (Phase 1)Ended earlyNCT02176486
What this trial is testing

Safety, Tolerability and Pharmacokinetics of Multiple Rising Doses of Ixazomib in Lupus Nephritis (LN)

Who this might be right for
Lupus Nephritis
Takeda 12
Testing effectiveness (Phase 2)Looking for participantsNCT06295770
What this trial is testing

Obinutuzumab in Treatment of Fibrillary Glomerulonephritis

Who this might be right for
Fibrillary Glomerulonephritis
Mayo Clinic 20
Very early researchNot Yet RecruitingNCT06690359
What this trial is testing

IM19 CAR-T Cell Therapy for IgA Nephropathy Patients and Membranous Nephropathy Patients

Who this might be right for
IgA NephropathyMembranous Nephropathy
Beijing Immunochina Medical Science & Technology Co., Ltd. 12
Not applicableUnknownNCT03864250
What this trial is testing

Tacrolimus Monotherapy for Idiopathic Membranous Nephropathy

Who this might be right for
TacrolimusIdiopathic Membranous NephropathyClinical Trial
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 124
Not applicableStudy completedNCT02765789
What this trial is testing

Immunoadsorption in Anti-GBM Glomerulonephritis.

Who this might be right for
Anti-glomerular Basement Membrane Glomerulonephritis
University Medical Center Groningen 8
Large-scale testing (Phase 3)Active Not RecruitingNCT03747159
What this trial is testing

Synergetic B-cell Immunomodulation in SLE - 2nd Study.

Who this might be right for
Lupus Erythematosus, Systemic
Leiden University Medical Center 70
Not applicableStudy completedNCT05337124
What this trial is testing

A Prospective Observational Registry of Patients Treated With LUPKYNIS® (Voclosporin) in the US

Who this might be right for
Lupus Nephritis
Aurinia Pharmaceuticals Inc. 229
Not applicableStudy completedNCT04689074
What this trial is testing

Establishment of the Human Intestinal and Salivary Microbiota Biobank - Kidney Diseases

Who this might be right for
Autosomal Dominant Polycystic Kidney Disease (ADPKD)Advanced-Chronic Kidney Disease (CKD)Diabetic Kidney Disease (DKD)+1 more
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari 150
Testing effectiveness (Phase 2)Study completedNCT03095118
What this trial is testing

Daratumumab in Treatment of PGNMID and C3 GN

Who this might be right for
Membranoproliferative Glomerulonephritis
Fernando Fervenza 12
Early research (Phase 1)Enrolling By InvitationNCT06518668
What this trial is testing

NKX019, a CD19 CAR NK Cell Therapy, in Subjects With Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Hospital for Special Surgery, New York 6
Not applicableUnknownNCT05528991
What this trial is testing

Oxford Classification and Clinical Remission After Initial Treatments in Patients With IgA Nephropathy

Who this might be right for
IgA Nephropathy
Shenzhen Second People's Hospital 474
Testing effectiveness (Phase 2)Study completedNCT01085097
What this trial is testing

Laquinimod in Participants With Systemic Lupus Erythematosus (SLE) Active Lupus Nephritis

Who this might be right for
Lupus Nephritis
Teva Branded Pharmaceutical Products R&D, Inc. 46
Post-approval studies (Phase 4)Looking for participantsNCT04662723
What this trial is testing

Multicentre Clinical Study to Evaluate the Effect of Personalized Therapy on Patients With Immunoglobulin A Nephropathy.

Who this might be right for
GlomerulonephritisImmunoglobulin A Nephropathy
Fondazione Schena 878
Large-scale testing (Phase 3)Study completedNCT01955187
What this trial is testing

Sequential Therapy With Tacrolimus and Rituximab in Primary Membranous Nephropathy

Who this might be right for
MEMBRANOUS NEPHROPATHY
Hospital Universitario 12 de Octubre 86
Not applicableLooking for participantsNCT02954419
What this trial is testing

IgA Nephropathy Biomarkers Evaluation Study (INTEREST)

Who this might be right for
IgA NephropathyGlomerular Diseases
Sun Yat-sen University 2,000
Testing effectiveness (Phase 2)UnknownNCT06113900
What this trial is testing

Assessment of Safety and Efficacy of SGLT2is Among LN Patients

Who this might be right for
Lupus Nephritis
Ain Shams University 50
Not applicableStudy completedNCT01835639
What this trial is testing

Vitamin D Supplementation in Glomerular Disease

Who this might be right for
Glomerular Disease
Children's Hospital of Philadelphia 32
Next Page